Previous 10 | Next 10 |
home / stock / ttoo / ttoo articles
CR Group LP, 10% Owner at T2 Biosystems (NASDAQ:TTOO), reported a large insider sell on September 27, according to a new SEC filing. What Happened...
CR Group LP, 10% Owner at T2 Biosystems (NASDAQ:TTOO), reported a large insider sell on September 26, according to a new SEC filing. What Happened...
The Nasdaq 100 closed higher by around 0.5% on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it ...
CR Group LP, 10% Owner at T2 Biosystems (NASDAQ:TTOO), reported a large insider sell on September 21, according to a new SEC filing. What Happened...
T2 Biosystems, Inc. (NASDAQ: TTOO) shares traded lower Tuesday as the stock pulled back following Monday's strength after the FDA cleared the c...
Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday. Avinger, Inc. (NASDAQ: AVGR) ...
Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 111% to $0.4000. Avinger, Inc. (NASDAQ: AVGR) surged 63.2% to $6.75 amid the company announcing...
T2 Biosystems, Inc. (NASDAQ: TTOO) shares are trading higher Monday after the FDA cleared the company's biothreat panel for commercial di...
Gainers T2 Biosystems, Inc. (NASDAQ: TTOO) shares rose 44.4% to $0.4003 in pre-market trading. T2 Biosystems said it issued inducement awards to f...
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a territory exclusive distribution agreement in Hong Kong and Macau. Under the terms ...
2024-06-18 09:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LEXINGTON, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it received written notice from the Nasdaq Stock Market LLC (ȁ...